DK1590351T3 - Fremgangsmåder til fremstilling af chinazolinalkaloider - Google Patents

Fremgangsmåder til fremstilling af chinazolinalkaloider

Info

Publication number: DK1590351T3
Authority: DK; Denmark
Prior art keywords: preparation; methods; quinazoline alkaloids; quinazoline; alkaloids
Prior art date: 2003-02-03

Application number

DK04704202T

Other languages

English (en)

Inventor

Joachim Moormann

Hans-Rainer Hoffmann

Rudolf Matusch

Original Assignee

Hf Arzneimittelforsch Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-03

Filing date

2004-01-22

Publication date

2008-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32747532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1590351(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-01-22 Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh

2008-12-15 Application granted granted Critical

2008-12-15 Publication of DK1590351T3 publication Critical patent/DK1590351T3/da

Links

229930002339 quinazoline alkaloid Natural products 0.000 title 1
125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Hospice & Palliative Care (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)

DK04704202T 2003-02-03 2004-01-22 Fremgangsmåder til fremstilling af chinazolinalkaloider DK1590351T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10304141A DE10304141B4 (de)	2003-02-03	2003-02-03	Verfahren zur Herstellung von Chinazolin-Alkaloiden
PCT/EP2004/000485 WO2004069836A1 (de)	2003-02-03	2004-01-22	Verfahren zur herstellung von chinazolin-alkaloiden

Publications (1)

Publication Number	Publication Date
DK1590351T3 true DK1590351T3 (da)	2008-12-15

Family

ID=32747532

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04704202T DK1590351T3 (da)	2003-02-03	2004-01-22	Fremgangsmåder til fremstilling af chinazolinalkaloider

Country Status (25)

Country	Link
US (1)	US7495096B2 (da)
EP (1)	EP1590351B1 (da)
JP (1)	JP2006516578A (da)
KR (1)	KR20050096165A (da)
CN (1)	CN100558727C (da)
AR (1)	AR042946A1 (da)
AT (1)	ATE407135T1 (da)
AU (1)	AU2004208873B2 (da)
BR (1)	BRPI0407012A (da)
CA (1)	CA2514945A1 (da)
DE (2)	DE10304141B4 (da)
DK (1)	DK1590351T3 (da)
EA (1)	EA009047B1 (da)
ES (1)	ES2314366T3 (da)
MX (1)	MXPA05008179A (da)
MY (1)	MY141734A (da)
NO (1)	NO20053689L (da)
NZ (1)	NZ541101A (da)
PL (1)	PL378406A1 (da)
PT (1)	PT1590351E (da)
SI (1)	SI1590351T1 (da)
TW (1)	TW200418811A (da)
UA (1)	UA81287C2 (da)
WO (1)	WO2004069836A1 (da)
ZA (1)	ZA200505160B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004048927A1 (de) *	2004-10-06	2006-04-20	Lts Lohmann Therapie-Systeme Ag	Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
EP3661502A4 (en)	2017-08-03	2020-12-02	Galectin Sciences, LLC	COMPOUNDS FOR THE PREVENTION AND TREATMENT OF MEDICAL CONDITIONS AND THEIR USES
KR102728780B1 (ko) *	2021-11-30	2024-11-08	이화여자대학교 산학협력단	데옥시바시시논을 유효성분으로 포함하는 미백용 조성물 및 상기 데옥시바시시논 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU605614A1 (ru) *	1971-10-20	1978-05-05	Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср	Антихолинэстеразное средство
JP3180464B2 (ja) *	1991-08-30	2001-06-25	新日本理化株式会社	ジアセタール化合物の製造方法
DE19530606A1 (de) *	1995-08-21	1997-02-27	Basf Ag	1-(Pyridyl)-pyrazole
JP3958452B2 (ja) *	1997-10-31	2007-08-15	大日精化工業株式会社	新規化学発光試薬及びその製造方法
DE19906975B4 (de)	1999-02-19	2004-04-15	Lts Lohmann Therapie-Systeme Ag	Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906979B4 (de)	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906978B4 (de)	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit

2003
- 2003-02-03 DE DE10304141A patent/DE10304141B4/de not_active Expired - Fee Related
2004
- 2004-01-22 DK DK04704202T patent/DK1590351T3/da active
- 2004-01-22 DE DE502004007980T patent/DE502004007980D1/de not_active Expired - Lifetime
- 2004-01-22 EA EA200501135A patent/EA009047B1/ru not_active IP Right Cessation
- 2004-01-22 AT AT04704202T patent/ATE407135T1/de active
- 2004-01-22 KR KR1020057013954A patent/KR20050096165A/ko not_active Ceased
- 2004-01-22 AU AU2004208873A patent/AU2004208873B2/en not_active Ceased
- 2004-01-22 WO PCT/EP2004/000485 patent/WO2004069836A1/de not_active Ceased
- 2004-01-22 US US10/544,265 patent/US7495096B2/en not_active Expired - Fee Related
- 2004-01-22 CN CNB2004800034182A patent/CN100558727C/zh not_active Expired - Fee Related
- 2004-01-22 ES ES04704202T patent/ES2314366T3/es not_active Expired - Lifetime
- 2004-01-22 NZ NZ541101A patent/NZ541101A/en not_active IP Right Cessation
- 2004-01-22 PL PL378406A patent/PL378406A1/pl not_active Application Discontinuation
- 2004-01-22 BR BR0407012-7A patent/BRPI0407012A/pt not_active Application Discontinuation
- 2004-01-22 JP JP2006501573A patent/JP2006516578A/ja active Pending
- 2004-01-22 EP EP04704202A patent/EP1590351B1/de not_active Expired - Lifetime
- 2004-01-22 CA CA002514945A patent/CA2514945A1/en not_active Abandoned
- 2004-01-22 MX MXPA05008179A patent/MXPA05008179A/es active IP Right Grant
- 2004-01-22 SI SI200430943T patent/SI1590351T1/sl unknown
- 2004-01-22 UA UAA200507716A patent/UA81287C2/uk unknown
- 2004-01-22 PT PT04704202T patent/PT1590351E/pt unknown
- 2004-01-28 AR ARP040100246A patent/AR042946A1/es unknown
- 2004-01-30 MY MYPI20040294A patent/MY141734A/en unknown
- 2004-02-02 TW TW093102290A patent/TW200418811A/zh unknown
2005
- 2005-06-24 ZA ZA200505160A patent/ZA200505160B/en unknown
- 2005-07-29 NO NO20053689A patent/NO20053689L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL378406A1 (pl)	2006-04-03
EA009047B1 (ru)	2007-10-26
MXPA05008179A (es)	2006-02-17
MY141734A (en)	2010-06-15
AU2004208873B2 (en)	2009-12-17
HK1075898A1 (zh)	2005-12-30
DE502004007980D1 (de)	2008-10-16
ZA200505160B (en)	2007-01-31
CA2514945A1 (en)	2004-08-19
US7495096B2 (en)	2009-02-24
KR20050096165A (ko)	2005-10-05
UA81287C2 (en)	2007-12-25
EP1590351B1 (de)	2008-09-03
EA200501135A1 (ru)	2006-02-24
ES2314366T3 (es)	2009-03-16
AU2004208873A1 (en)	2004-08-19
WO2004069836A1 (de)	2004-08-19
US20060084669A1 (en)	2006-04-20
BRPI0407012A (pt)	2006-01-10
PT1590351E (pt)	2008-11-21
DE10304141B4 (de)	2006-03-09
CN100558727C (zh)	2009-11-11
JP2006516578A (ja)	2006-07-06
AR042946A1 (es)	2005-07-06
TW200418811A (en)	2004-10-01
DE10304141A1 (de)	2004-08-26
EP1590351A1 (de)	2005-11-02
NZ541101A (en)	2009-03-31
SI1590351T1 (sl)	2009-02-28
ATE407135T1 (de)	2008-09-15
NO20053689L (no)	2005-07-29
CN1745084A (zh)	2006-03-08

Publication	Publication Date	Title
DK1828164T3 (da)	2008-12-08	Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK3029040T3 (da)	2019-06-24	Fremgangsmåde til fremstilling af chirale 8-(3-amino-piperidin-1-yl)-xanthiner
DK1778668T3 (da)	2013-09-30	Fremgangsmåde til fremstilling af dihydropteridion
DK2308507T3 (da)	2015-04-20	Fremgangsmåder til behandling af præeklampsi
DK1830956T3 (da)	2023-02-06	Fremgangsmåde til forberedelse af katalytiske materialer
DE602004004553D1 (de)	2007-03-15	Chinazolinderivate
DK1748077T3 (da)	2013-04-08	Fremgangsmåde til fremstilling af protein
DE602004022180D1 (de)	2009-09-03	Chinazolinderivate
DK1791820T3 (da)	2010-04-06	Enantioselektiv fremstilling af quinolinderivater
DK1611108T3 (da)	2011-10-10	Fremgangsmåde til fremstilling af telmisartan
DK1840125T3 (da)	2009-11-09	Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
ATE413389T1 (de)	2008-11-15	Chinazolinderivate
DK1546122T3 (da)	2008-03-03	Fremgangsmåde til fremstilling af valsartan
DK1667967T3 (da)	2012-10-08	Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1480953T4 (da)	2010-11-15	Fremgangsmåde til fremstilling af aripiprazol
DK1575941T3 (da)	2012-07-09	Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1678135T3 (da)	2009-09-07	Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1456229T3 (da)	2010-01-04	Fremgangsmåe til fremstilling af echinocandin-derivater
DK1838683T3 (da)	2009-08-10	Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
DK1682541T3 (da)	2010-06-28	Fremgangsmåde til fremstilling af tiotropiumsalte
DK1831223T3 (da)	2013-06-10	Fremgangsmåde til fremstilling af L-biopterin
DK1660485T3 (da)	2007-03-19	Forbedret fremgangsmåde til fremstilling af alpha-polymorfisk eletriptanhydrobromid
DK1805316T3 (da)	2009-08-10	Fremgangsmåde til fremstilling af de enantiomere former af cis-3-hydroxycy-
DK1692137T3 (da)	2007-04-30	Fremgangsmåde til fremstilling af tubulinininhibitorer
DK1511724T3 (da)	2014-06-16	Fremgangsmåde til fremstilling af thioalkylaminderivater